ConductScience.org, home

Paper40201683

Multigenetic pharmacogenomics-guided treatment shows greater improvements on motor symptoms compared to usual therapy in Parkinson's disease: a small real-word prospective cohort study.

Li Y and 7 others. Front Pharmacol, 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Multigenetic pharmacogenomics-guided treatment shows greater improvements on motor symptoms compared to usual therapy in Parkinson's disease: a small real-word prospective cohort study. Papers, record 40201683. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40201683

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Multigenetic pharmacogenomics-guided treatment shows greater improvements on motor symptoms compared to usual therapy in Parkinson's disease: a small real-word prospective cohort study.
PubMed
Journal
Front Pharmacol
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2025-04-10
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li YYifan
2Li MMao
3Wang MMiao
4Yao JJiarui
5Li FFengzhu
6Chen SSiyu
7Yin XXi
8Gao ZZhongbao

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133039854Contribution of functional dopamine D2 and D3 receptor variants to motor and non-motor symptoms of early onset Parkinson's disease.Clin Neurol Neurosurg2020https://conductscience.org/library/papers/33039854PubMed
233250838Polymorphism of the Dopa-Decarboxylase Gene Modifies the Motor Response to Levodopa in Chinese Patients With Parkinson's Disease.Front Neurol2020https://conductscience.org/library/papers/33250838PubMed
321663922Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium.J Neurol Sci2011https://conductscience.org/library/papers/21663922PubMed
415115919A novel polymorphism in the promoter region of human UGT1A9 gene (UGT1A9*22) and its effects on the transcriptional activity.Pharmacogenetics2004https://conductscience.org/library/papers/15115919PubMed
521278619Metabolic acidosis with topiramate and zonisamide: an assessment of its severity and predictors.Pharmacogenet Genomics2011https://conductscience.org/library/papers/21278619PubMed
627751556The epidemiology of Parkinson's disease: risk factors and prevention.Lancet Neurol2016https://conductscience.org/library/papers/27751556PubMed
727817855Association of the DRD2 CAn-STR and DRD3 Ser9Gly polymorphisms with Parkinson's disease and response to dopamine agonists.J Neurol Sci2017https://conductscience.org/library/papers/27817855PubMed
827190009Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson's disease: a pharmacogenetic study.Brain2016https://conductscience.org/library/papers/27190009PubMed
932022467Gene polymorphisms and motor levodopa-induced complications in Parkinson's disease.Brain Behav2020https://conductscience.org/library/papers/32022467PubMed
1037801319Multigenetic Pharmacogenomics-Guided Treatment vs Treatment As Usual Among Hospitalized Men With Schizophrenia: A Randomized Clinical Trial.JAMA Netw Open2023https://conductscience.org/library/papers/37801319PubMed
1115355491The effect of monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson's disease.Acta Neurol Scand2004https://conductscience.org/library/papers/15355491PubMed
1215640376Transport of the dopamine D2 agonist pramipexole by rat organic cation transporters OCT1 and OCT2 in kidney.Drug Metab Dispos2005https://conductscience.org/library/papers/15640376PubMed
1335079903
Polymorphisms of the dopamine metabolic and signaling pathways are associated with susceptibility to motor levodopa-induced complications (MLIC) in Parkinson's disease: a systematic review and meta-analysis.
Neurol Sci2022https://conductscience.org/library/papers/35079903PubMed
1430677646Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study.J Psychiatr Res2019https://conductscience.org/library/papers/30677646PubMed
1523565891Anti-Parkinson's disease drugs and pharmacogenetic considerations.Expert Opin Drug Metab Toxicol2013https://conductscience.org/library/papers/23565891PubMed
1633641259Pharmacogenomics guided versus standard antidepressant treatment in a community pharmacy setting: A randomized controlled trial.Clin Transl Sci2021https://conductscience.org/library/papers/33641259PubMed
1725686762Clinical validity: Combinatorial pharmacogenomics predicts antidepressant responses and healthcare utilizations better than single gene phenotypes.Pharmacogenomics J2015https://conductscience.org/library/papers/25686762PubMed
1821280081The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: a randomized crossover clinical trial.Ann Neurol2011https://conductscience.org/library/papers/21280081PubMed
199204539Opossum kidney cells take up L-DOPA through an organic cation potential-dependent and proton-independent transporter.Cell Biol Int1997https://conductscience.org/library/papers/9204539PubMed
2018698234The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications.Pharmacogenet Genomics2008https://conductscience.org/library/papers/18698234PubMed

See all 39 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn Papers
41222708Pharmacogenetics in advanced Parkinson's disease.J Neural Transm (Vienna)2025https://conductscience.org/library/papers/41222708

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40201683

GET https://conductscience.org/api/papers/v1/40201683/references?page=2